Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : View from the Center and Left -- Ignore unavailable to you. Want to Upgrade?

To: Rambi who wrote (119650)	8/27/2009 7:19:36 PM
From: Bearcatbob	Respond to of 541957

Rambi - when I have brought up Tort reform I have been soundly informed that Tort was not a matter of sufficient cost concern to be of merit.

To: Rambi who wrote (119650)	8/28/2009 2:52:09 PM
From: greenspirit	Read Replies (1) \| Respond to of 541957

The "deal" needs to be made with the American people, not special interest lobby groups. Not addressing TORT reform is an admission of back-room deal making at the expense of meaningful reform. A few studies can be massaged to say just about anything. When you talk to real people who are living and working in the health care system, they know the cost of defensive medicine is huge. And it's no secret to the American people. I'll go out on a limb and say a major health care bill, which does not contain some form of TORT reform will not pass Congress this year, even with the addition of all those eyes swelling up over the death of Ted Kennedy.